Senior Director, Field Medical Lead-West at Vor Bio

Remote

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess an advanced scientific degree (PharmD, PhD, MD, or equivalent) and at least 5 years of experience as a Medical Science Liaison (MSL) in neurology, rheumatology, or immunology. Demonstrated excellence in scientific exchange, KOL engagement, and medical insights generation is required, along with strong communication, interpersonal, and coaching/mentoring skills. The ability to work independently and collaboratively in a matrix environment is essential, and candidates must reside in the US Central or Western time zones. Experience supporting clinical trial execution and medical launch activities is strongly preferred, as is readiness for formal people leadership and/or medical strategy roles.

Responsibilities

The Senior Director, Field Medical Lead will serve as the scientific face of the company in the West territory, engaging with healthcare professionals, KOLs, investigators, and advocacy groups to conduct scientific exchange and communicate data. Responsibilities include supporting clinical trial execution through site engagement, capturing and relaying field medical insights, and representing the company at scientific congresses. Additionally, the role involves serving as a core member of the Medical Affairs Leadership Team, leading, mentoring, and coaching MSLs, supporting hiring and onboarding, contributing to field execution frameworks, partnering on territory planning and KOL mapping, and leading regional initiatives.

Skills

Medical Affairs

MSL Leadership

Medical Strategy

Neurology

Rheumatology

KOL Engagement

Clinical Development

Commercial Strategy

Autoimmune Diseases

Vor Bio

Develops targeted therapies for blood cancers

About Vor Bio

Vor Biopharma focuses on developing treatments for blood cancers, particularly Acute Myeloid Leukemia (AML). Their approach is designed to protect healthy cells while specifically targeting and eliminating cancerous cells. This method aims to improve the effectiveness of blood cancer treatments. Vor Biopharma serves patients with blood cancers, their caregivers, and medical professionals in hospitals and oncology centers. What sets Vor Biopharma apart from competitors is their strong emphasis on research and development, investing significantly in scientific research to create a proprietary platform and pipeline of therapies. They generate revenue through partnerships with other pharmaceutical companies and licensing agreements, with the goal of commercializing their therapies after obtaining regulatory approval. The company's mission is to transform the treatment landscape for blood cancers by providing innovative therapies that prioritize patient safety and efficacy.

Cambridge, MassachusettsHeadquarters

2015Year Founded

$147.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees